| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.27 | 0.0005 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0007 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0008 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.001 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.14 | 0.002 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.11 | 0.002 |